Amy Allina News
-
Allergan Inc. won’t seek U.S. clearance to sell its popular Lap-Band stomach shrinking device to an increasing population of obese teenagers.
-
Johnson & Johnson, the world’s second-biggest health-care products maker, is battling lawsuits over a vaginal implant based on a similar device pulled from the market more than a decade ago for safety reasons.
-
Teva Pharmaceutical Industries Ltd.’s emergency contraceptive may be the first approved for over-the- counter use by females of any age under a decision being considered by U.S. regulators.
-
Teva Pharmaceutical Industries Ltd.’s emergency contraceptive may be the first approved for over-the- counter use by females of all ages if U.S. regulators today lift restrictions.
-
Johnson & Johnson and C.R. Bard Inc. must study rates of organ damage and complications linked to vaginal mesh implants, U.S. regulators said, responding to patient advocates who say the devices have harmed women.
-
Johnson & Johnson and C.R. Bard Inc. must study rates of organ damage and complications linked to vaginal mesh implants, U.S. regulators said, responding to patient advocates who say the devices have harmed women.
-
A reproductive rights group asked a federal judge to reopen a lawsuit over access to the emergency contraceptive Plan B, claiming the Food and Drug Administration acted in “bad faith” when it placed restrictions on the drug.
-
Teva Pharmaceutical Industries Ltd. failed to win U.S. clearance for the first over-the-counter emergency contraceptive after an Obama Cabinet member overruled the head of the Food and Drug Administration on the issue.
|
|
Most Popular on Bloomberg
|
| |